QuikSTART Grant

Center for Drug Discovery – Siteman Cancer Center 

QuikSTART Grant Application


The Center for Drug Discovery (CDD) and the Siteman Cancer Center partnered to establish the QuikSTART Grant program. The $15,000 award is designed to to advance the translation of new discoveries in cancer disease biology into small molecule therapeutics for the benefit of patients. CDD offers a full suite of preclinical drug discovery services and know-how. Capabilities range from drug lead finding utilizing the High Throughput Screening Core to Medicinal Chemistry-driven drug lead optimization, ADME profiling, and in vivo pharmacokinetics, furnishing drug-like molecules for proof-of-conceptin vivopharmacology studies and intellectual property (patent) filing.


Eligibility criteria. Washington University faculty (Assistant professor and above) holding Siteman Cancer Center membership.

Submission deadline & award notification. Submissions occur 3X annually on March 31, July 31, and November 30. Applications may be confidentially evaluated by an external advisory committee. Award decisions are communicated within 4 weeks.

Award term. The funds are available for 1 year.

Expectation. The QuikSTART award is viewed as a “hand-up” to generate preliminary data to enable successful following-on funding (e.g., NCI, NIH, private foundation, commercial partnership), publication, and patent filing.

Reporting. Final reports are required upon project completion. Investigators will be surveyed annually for 3 years after the award expires to capture the return on investment (e.g., publications, grant submissions, other outcomes) for the funding program.

Pre-consultation. Applicants are advised to consult with CDD prior to proposal submission.


Application process:

  • Download application form here.
  • Submit completed application along with a current Biosketch or CV to Ron Dolle.


The 2022 summer submission deadline has now been extended to September 15, 2022.